Results 11 to 20 of about 76,843 (254)
Vaccinia Gangrenosa: The Report of a Case of Prolonged Generalized Vaccinia [PDF]
Archives of Disease in Childhood, 1952 B M Laurance +2 more
openalex +4 more sources
Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses
Frontiers in Immunology, 2020 We conducted a large genome-wide association study (GWAS) of the immune responses to primary smallpox vaccination in a combined cohort of 1,653 subjects.
Richard B. Kennedy +8 more
doaj +1 more source
Frontiers in Immunology, 2021 Respiratory syncytial virus (RSV) is a leading cause of respiratory infections worldwide and disease management measures are hampered by the lack of a safe and effective vaccine against the infection.
Marsha S. Russell +18 more
doaj +1 more source
Molecular Therapy: Oncolytics, 2023 Tumor-specific overexpression of receptors enables a variety of targeted cancer therapies, exemplified by peptide-receptor radiotherapy (PRRT) for somatostatin receptor (SSTR)-positive neuroendocrine tumors.
Kathryn Ottolino-Perry +9 more
doaj +1 more source
Viruses, 2023 The ongoing global Monkeypox outbreak that started in the spring of 2022 has reinforced the importance of protecting the population using live virus vaccines based on the vaccinia virus (VACV).
Ryan S. Noyce +10 more
doaj +1 more source
The Rise and Fall of Modern Plagues
Molecular Frontiers Journal, 2020 Millennia separate smallpox, the oldest pandemic, and COVID-19, the newest. Both calamities arose from an opportunistic virus amid human crowding. A vaccine for smallpox existed since the late 18th century, but it took worldwide public health strategy to
G. Terry Sharrer
doaj +1 more source
Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
Emerging Infectious Diseases, 2023 Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age.
Iván Sanz-Muñoz +9 more
doaj +1 more source
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Journal of Immunotherapy for Cancer, 2019 Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer.
Z. Guo +10 more
semanticscholar +1 more source
When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond
Journal of Infection in Developing Countries, 2008 The presence of zoonotic poxviruses in nature represents a potential human health risk that has to be re-evaluated by health authorities not only in developing countries, but also in many developed countries.
Nissin Moussatché,1,2 Clarissa R. Damaso,2 and Grant McFadden1
doaj +3 more sources